What is the appropriate treatment for enteritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Enteritis

The treatment of enteritis depends critically on the underlying etiology and severity: for sexually transmitted enteritis (from oral-anal contact), supportive care with oral rehydration is primary; for bacterial gastroenteritis, oral rehydration solution is first-line with antimicrobials reserved for specific indications; and for inflammatory bowel disease-related enteritis, multidisciplinary management with IV fluids, thromboprophylaxis, and selective antibiotics for superinfection is essential. 1, 2, 1

Sexually Transmitted Enteritis

Clinical Context

  • Enteritis from sexual transmission typically results from oral-anal contact and presents with diarrhea and abdominal cramping without signs of proctitis or proctocolitis 1
  • In otherwise healthy persons, Giardia lamblia is most frequently implicated 1
  • Among HIV-infected persons, additional pathogens including CMV, Mycobacterium avium-intracellulare, Salmonella, Campylobacter, Shigella, Cryptosporidium, and Microsporidium should be considered 1

Management Approach

  • Supportive care with oral rehydration is the cornerstone of treatment 1, 2
  • Diagnostic evaluation should include appropriate stool examination and culture to identify the specific pathogen 1
  • Antimicrobial therapy should be pathogen-directed once identified 1

Bacterial Gastroenteritis/Enteritis

Primary Treatment: Rehydration

Oral rehydration solution (ORS) is the definitive first-line therapy for mild to moderate dehydration and should be initiated immediately 2

ORS Dosing Specifics

  • Mild to moderate dehydration: Administer 50-100 mL/kg over 3-4 hours in infants/children, or 2-4 L in adolescents/adults 2
  • Children <10 kg: Give 60-120 mL ORS after each diarrheal stool or vomiting episode (maximum ~500 mL/day) 2
  • Children >10 kg: Give 120-240 mL ORS after each diarrheal stool or vomiting episode (maximum ~1 L/day) 2
  • Adolescents/adults: Provide ad libitum ORS, up to ~2 L/day 2

Severe Dehydration

  • For severe dehydration, shock, altered mental status, or ileus: Administer isotonic IV fluids (lactated Ringer's or normal saline) at 20 mL/kg boluses until pulse, perfusion, and mental status normalize 2
  • Nasogastric ORS administration may be considered for moderate dehydration when oral intake is not tolerated 2

Antimicrobial Therapy: Selective Use Only

Empiric antimicrobials are NOT recommended for most bacterial gastroenteritis cases 2

Specific Indications for Antimicrobials

Antibiotics should be considered ONLY in these situations:

  • Infants <3 months with suspected bacterial etiology 2
  • Immunocompromised patients with severe illness and bloody diarrhea 2
  • Patients with fever, abdominal pain, bloody diarrhea, and bacillary dysentery 2
  • Documented specific pathogens requiring treatment 2

Antimicrobial Selection When Indicated

  • Adults: Fluoroquinolones (ciprofloxacin) or azithromycin, guided by local susceptibility patterns and travel history 2
  • Children: Third-generation cephalosporin or azithromycin 2
  • Pathogen-specific therapy:
    • Campylobacter: Azithromycin 2
    • Shigella: Ciprofloxacin or another fluoroquinolone 2
    • Salmonella: Ciprofloxacin, TMP-SMX, or amoxicillin 2

Critical Pitfall

NEVER give antibiotics for STEC O157 infections—they increase the risk of hemolytic uremic syndrome 2

Symptomatic Management

Antimotility Agents

  • Loperamide is CONTRAINDICATED in children <18 years 2
  • Adults with watery diarrhea: Initial dose 4 mg orally, then 2 mg after each loose stool (maximum 16 mg/day) 2, 1
  • Avoid loperamide in: Inflammatory diarrhea, bloody diarrhea, or fever 2

Antiemetics

  • Ondansetron may be given to children >4 years and adolescents with vomiting to facilitate oral rehydration 2

Adjunctive Therapies

  • Probiotics may reduce symptom severity and duration in immunocompetent patients 2
  • Zinc supplementation reduces diarrhea duration in children 6 months to 5 years in high zinc deficiency areas or malnourished children 2

Nutritional Management

  • Resume age-appropriate diet immediately after rehydration is completed—solid food does not delay recovery 2
  • Small, light meals guided by appetite are appropriate once rehydrated 2
  • Avoid fatty, heavy, spicy foods, caffeine, and lactose-containing foods if diarrhea is prolonged 2

Inflammatory Bowel Disease-Related Enteritis

Initial Management

All IBD patients presenting with acute abdomen require multidisciplinary management involving gastroenterology and acute care surgery 1

Immediate Interventions

  • Adequate volume of IV fluids 1
  • Low molecular weight heparin for thromboprophylaxis 1
  • Correct electrolyte abnormalities and anemia 1

Antibiotic Use in IBD Enteritis

Antibiotics should NOT be routinely administered—only for superinfection or intra-abdominal abscess 1

When Antibiotics Are Indicated

  • For superinfection or abscesses: Prompt antimicrobial therapy against Gram-negative aerobic/facultative bacilli, Gram-positive streptococci, and obligate anaerobic bacilli 1
  • Recommended regimens: Fluoroquinolones or third-generation cephalosporin PLUS metronidazole 1
  • Duration depends on clinical features and laboratory results (e.g., serum CRP level) 1

Abscess Management

  • Abscesses >3 cm: Percutaneous drainage with antibiotics is first-line treatment 1
  • Abscesses <3 cm: May be treated with IV antibiotics alone, though recurrence risk is higher, especially with enteric fistula 1
  • Clinical improvement should occur within 3-5 days; if not, re-evaluate and consider repositioning drain or surgery 1

Disease-Specific Medical Therapy

Ulcerative Colitis

  • Severe active UC in hemodynamically stable patients: IV corticosteroids 1
  • Assess response by day 3 1
  • Non-responders: Consider medical rescue therapy with infliximab plus thiopurine, or ciclosporin in multidisciplinary approach 1

Crohn's Disease

  • Infliximab should be considered for penetrating ileocecal Crohn's disease requiring anti-inflammatory therapy, following adequate resolution of intra-abdominal abscesses 1
  • For complex perianal fistulizing disease: Infliximab or adalimumab as first-line therapy combined with azathioprine, following adequate surgical drainage if indicated 1
  • Combination of ciprofloxacin and anti-TNF improves short-term outcomes 1

Nutritional Support

  • Preoperative nutritional support is mandatory in severely undernourished patients 1
  • Total parenteral nutrition reserved for patients unable to tolerate enteral nutrition or when enteral route is contraindicated (shock, intestinal ischemia, high output fistula, severe hemorrhage) 1
  • TPN is the mode of choice when emergency surgery is needed for complicated IBD 1

Complicated Diarrhea (Cancer Patients)

Classification and Management

Patients with moderate to severe cramping, nausea/vomiting, diminished performance status, fever, sepsis, neutropenia, bleeding, or dehydration are classified as "complicated" and require hospitalization 1

Intensive Management Protocol

  • Hospital admission with IV fluids 1
  • Octreotide: Starting dose 100-150 mcg subcutaneously three times daily, or IV 25-50 mcg/hour if severely dehydrated, with dose escalation up to 500 mcg subcutaneously three times daily until controlled 1
  • Antibiotics: Fluoroquinolones or metronidazole 1
  • Laboratory evaluation: Complete blood count, electrolyte profile, stool work-up for blood, C. difficile, Salmonella, E. coli, Campylobacter, and infectious colitis 1

Neutropenic Enterocolitis

This is a medical emergency with high mortality risk requiring aggressive initial medical management 1

Medical Management

  • Broad-spectrum antibiotics covering enteric Gram-negatives, Gram-positives, and anaerobes 1
  • Reasonable initial choices: Piperacillin-tazobactam or imipenem-cilastatin monotherapy, OR cefepime/ceftazidime plus metronidazole 1
  • G-CSF administration 1
  • Nasogastric decompression 1
  • IV fluids and bowel rest 1
  • Serial abdominal examinations 1
  • Consider amphotericin if no response to antibacterials (fungemia is common) 1
  • Blood transfusions may be necessary for bloody diarrhea 1

Critical Contraindication

AVOID anticholinergic, antidiarrheal, and opioid agents—they may aggravate ileus 1

Surgical Indications

  • Persistent GI bleeding after correcting thrombocytopenia/coagulopathy 1
  • Free intraperitoneal perforation 1
  • Abscess formation 1
  • Clinical deterioration despite aggressive supportive measures 1
  • If surgery is performed: Resect all necrotic bowel (usually right hemicolectomy, ileostomy, and mucous fistula); primary anastomosis is NOT recommended due to high leak risk 1

Monitoring and Red Flags

Continue Monitoring Until Resolution

  • Hydration status 2
  • Electrolyte balance 2
  • Nutritional status 2

Seek Immediate Medical Care If

  • No improvement within 48 hours 2
  • Symptoms worsen or overall condition deteriorates 2
  • Severe vomiting preventing oral intake 2
  • Persistent fever 2
  • Frank blood in stools 2
  • Abdominal distension 2

Infection Control

  • Hand hygiene after toilet use, diaper changes, before/after food preparation, and before eating 2
  • Use gloves, gowns, and proper hand hygiene when caring for patients with diarrhea 2
  • Asymptomatic contacts do not need treatment but should follow infection prevention measures 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Bacterial Gastroenteritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.